Drug therapy  of mesenteric ischemia        YUE Jia-ning, FU Wei-guo. Department of Vascular Surgery, Zhongshan Hospital Fudan University,Shanghai200032,China
Corresponding author：FU Wei-guo,E-mail: fu.weiguo@zs-hospital.sh.cn
Abstract    Any condition that results in the decreased blood flow to the bowel may cause acute or chronic mesenteric ischemia. While surgical revascularization and intestinal resection has still been the standard of treatment, supportive therapy and medical management play important roles in the comprehensive surgical strategy. In patients without clinical evidence of bowel infarction, conservative medical therapy may be the primary strategy. Even in the irreversible bowel ischemia, perioperative drug therapy is crucial to the success of the surgery. Long-term drug therapy may be necessary to keep the graft or stent functional, as well as to control the systematic risk factors.